Lyndal K Hesterberg

Introduction

Lyndal K. Hesterberg is a distinguished inventor based in Boulder, Colorado, recognized for her significant contributions to biopharmaceutical technologies. With a focus on antibody refolding and protein solubilization, her work has led to important advancements in the production of therapeutic proteins.

Latest Patents

Hesterberg holds two patents that showcase her innovative approaches in biochemistry. The first patent, titled "High Pressure Refolding of Monoclonal Antibody Aggregates," describes methods for refolding antibodies from aggregated or denatured preparations by applying high hydrostatic pressure. This technique not only improves the recovery of functional antibodies but also enhances their overall quality. Her second patent, "High-Pressure Inclusion Body Solubilization and Protease Clipping of Recombinant Fusion Proteins," details methods for solubilizing fusion protein aggregates at pressures exceeding atmospheric levels, enabling the production of soluble target polypeptides.

Career Highlights

Lyndal K. Hesterberg is currently employed at Barofold, Inc. Her career is marked by a commitment to innovation in the field of protein science, where she continues to develop technologies that address challenges in the production and stabilization of biologic therapies.

Collaborations

Throughout her career, Hesterberg has collaborated with notable professionals such as Matthew B. Seefeldt and Theodore W. Randolph. These collaborations have fostered a culture of knowledge sharing and innovation, enriching her research and leading to impactful advancements in her field.

Conclusion

Lyndal K. Hesterberg exemplifies the spirit of innovation in the biopharmaceutical industry. Through her groundbreaking patents and collaborative efforts, she continues to contribute significantly to the advancement of therapeutic protein technologies, paving the way for improved healthcare solutions.